Barr Submits Plan B Response To FDA, Starts 180-Day Review Clock
This article was originally published in The Pink Sheet Daily
Executive Summary
Response to "not approvable" letter for OTC availability of the emergency contraceptive includes information supporting Rx-only status for women 15 years of age and under and OTC status for women 16 and older.